The U.S. Food and Drug Administration on Monday approved the emergency use of Pfizer’s booster shot against COVID-19 for youths aged 12 to 15. The move comes as the Omicron variant spreads across the country and students return to classrooms following the holiday break. “Throughout the pandemic, as the virus that causes COVID-19 has continuously…  read on >  read on >

(HealthDay News) – New animal research offers a compelling explanation as to how the Omicron variant causes less severe disease than some of its predecessors: It seems to settle in the nose, throat and windpipe, rather than traveling down to the lungs. “It’s fair to say that the idea of a disease that manifests itself…  read on >  read on >

An international trial found that a once-a-day antiretroviral medication for kids with HIV is not only cheap and easy to take, but also better at suppressing HIV than standard treatments. “Our findings provide strong evidence for the global rollout of dolutegravir for children with HIV,” said Dr. Diana Gibb, a professor of epidemiology at University…  read on >  read on >

FRIDAY, Dec.31, 2021When a sick child spends time in the intensive care unit, the impact lasts even after the hospital stay is over. Added to it are days, weeks, sometimes months out of school for the young patient and extended work absences for their primary caregivers. “Pediatric critical illness impacts a family’s health and well-being…  read on >  read on >

By now, most folks know obesity is a leading risk factor for severe COVID-19, but a new study suggests that losing a significant amount of weight can reduce that risk. “The research findings show that patients with obesity who achieved substantial and sustained weight loss with bariatric [weight-loss] surgery prior to a COVID-19 infection reduced…  read on >  read on >

Younger adolescents may soon be eligible for COVID-19 booster vaccines, possibly by early next week. The U.S. Food and Drug Administration is planning on Monday to broaden booster eligibility to include 12- to 15-year-olds, sources told the New York Times. This would be for the Pfizer-BioNTech shot, currently the only COVID-19 vaccine approved for this…  read on >  read on >